APO Research

APO RESEARCH · REPORT

Life Science Products

Selected research

Market Outlook & Growth Opportunities

Global Life Science Products Market Outlook and Growth Opportunities 2026

Market perspective

The global Life Science Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Life Science Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Life Science Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Life Science Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Life Science Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Life Science Products market include Thermo Fisher Scientific, Sigma Aldrich Corp, PerkinElmer, Merck Millipore Limited, Genscript Biotech Corporation, Crown Bioscience, BPS Bioscience, Bio-Rad Laboratories and Abcam, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Life Science Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Life Science Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Life Science Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Life Science Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Life Science Products Segment by Company

Thermo Fisher Scientific

Sigma Aldrich Corp

PerkinElmer

Merck Millipore Limited

Genscript Biotech Corporation

Crown Bioscience

BPS Bioscience

Bio-Rad Laboratories

Abcam

A.M.S. Biotechnology (Europe)

Life Science Products Segment by Type

Recombinant Proteins

Tumor Tissue Microarrays

Cell Lines

Antibodies

Viable Tumor Samples

Others

Life Science Products Segment by Application

Forensic Science Laboratories

Contract Research Organizations (CROs)

Biopharmaceutical Companies

Food & Beverage Companies

Academic & Research Institutes

Diagnostic Centers

Others

Life Science Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Life Science Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Life Science Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Life Science Products significant trends, drivers, influence factors in global and regions.

6. To analyze Life Science Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Life Science Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Life Science Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Life Science Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Life Science Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Life Science Products industry.

Chapter 3: Detailed analysis of Life Science Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Life Science Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Life Science Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Life Science Products Industry Trends Table 2. Life Science Products Industry Drivers Table 3. Life Science Products Industry Opportunities and Challenges Table 4. Life Science Products Industry Restraints Table 5. Global Life Science Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Life Science Products Revenue Share by Company (2021-2026) Table 7. Global Life Science Products Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Life Science Products Sales Volume Share by Company (2021-2026) Table 9. Global Life Science Products Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Life Science Products Company Ranking, (2024-2026) & (USD Million) Table 11. Global Life Science Products Key Company Manufacturing Base & Headquarters Table 12. Global Life Science Products Company, Product Type & Application Table 13. Global Life Science Products Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Life Science Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Recombinant Proteins Table 18. Significant Companies of Tumor Tissue Microarrays Table 19. Significant Companies of Cell Lines Table 20. Significant Companies of Antibodies Table 21. Significant Companies of Viable Tumor Samples Table 22. Significant Companies of Others Table 23. Global Life Science Products Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Life Science Products Sales Volume by Type (2021-2026) & (W Units) Table 25. Global Life Science Products Sales Volume by Type (2027-2032) & (W Units) Table 26. Global Life Science Products Sales Volume Share by Type (2021-2026) Table 27. Global Life Science Products Sales Volume Share by Type (2027-2032) Table 28. Global Life Science Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Life Science Products Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Life Science Products Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Life Science Products Sales Value Share by Type (2021-2026) Table 32. Global Life Science Products Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Forensic Science Laboratories Table 34. Significant Companies of Contract Research Organizations (CROs) Table 35. Significant Companies of Biopharmaceutical Companies Table 36. Significant Companies of Food & Beverage Companies Table 37. Significant Companies of Academic & Research Institutes Table 38. Significant Companies of Diagnostic Centers Table 39. Significant Companies of Others Table 40. Global Life Science Products Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 41. Global Life Science Products Sales Volume by Application (2021-2026) & (W Units) Table 42. Global Life Science Products Sales Volume by Application (2027-2032) & (W Units) Table 43. Global Life Science Products Sales Volume Share by Application (2021-2026) Table 44. Global Life Science Products Sales Volume Share by Application (2027-2032) Table 45. Global Life Science Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Life Science Products Sales Value by Application (2021-2026) & (US$ Million) Table 47. Global Life Science Products Sales Value by Application (2027-2032) & (US$ Million) Table 48. Global Life Science Products Sales Value Share by Application (2021-2026) Table 49. Global Life Science Products Sales Value Share by Application (2027-2032) Table 50. Global Life Science Products Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 51. Global Life Science Products Sales by Region (2021-2026) & (W Units) Table 52. Global Life Science Products Sales Market Share by Region (2021-2026) Table 53. Global Life Science Products Sales by Region (2027-2032) & (W Units) Table 54. Global Life Science Products Sales Market Share by Region (2027-2032) Table 55. Global Life Science Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Life Science Products Sales Value by Region (2021-2026) & (US$ Million) Table 57. Global Life Science Products Sales Value Share by Region (2021-2026) Table 58. Global Life Science Products Sales Value by Region (2027-2032) & (US$ Million) Table 59. Global Life Science Products Sales Value Share by Region (2027-2032) Table 60. Global Life Science Products Market Average Price (US$/Unit) by Region (2021-2026) Table 61. Global Life Science Products Market Average Price (US$/Unit) by Region (2027-2032) Table 62. Global Life Science Products Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 63. Global Life Science Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Life Science Products Sales by Country (2021-2026) & (W Units) Table 65. Global Life Science Products Sales Market Share by Country (2021-2026) Table 66. Global Life Science Products Sales by Country (2027-2032) & (W Units) Table 67. Global Life Science Products Sales Market Share by Country (2027-2032) Table 68. Global Life Science Products Sales Value by Country (2021-2026) & (US$ Million) Table 69. Global Life Science Products Sales Value Market Share by Country (2021-2026) Table 70. Global Life Science Products Sales Value by Country (2027-2032) & (US$ Million) Table 71. Global Life Science Products Sales Value Market Share by Country (2027-2032) Table 72. Thermo Fisher Scientific Company Information Table 73. Thermo Fisher Scientific Business Overview Table 74. Thermo Fisher Scientific Life Science Products Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Thermo Fisher Scientific Life Science Products Product Portfolio Table 76. Thermo Fisher Scientific Recent Development Table 77. Sigma Aldrich Corp Company Information Table 78. Sigma Aldrich Corp Business Overview Table 79. Sigma Aldrich Corp Life Science Products Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sigma Aldrich Corp Life Science Products Product Portfolio Table 81. Sigma Aldrich Corp Recent Development Table 82. PerkinElmer Company Information Table 83. PerkinElmer Business Overview Table 84. PerkinElmer Life Science Products Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. PerkinElmer Life Science Products Product Portfolio Table 86. PerkinElmer Recent Development Table 87. Merck Millipore Limited Company Information Table 88. Merck Millipore Limited Business Overview Table 89. Merck Millipore Limited Life Science Products Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Merck Millipore Limited Life Science Products Product Portfolio Table 91. Merck Millipore Limited Recent Development Table 92. Genscript Biotech Corporation Company Information Table 93. Genscript Biotech Corporation Business Overview Table 94. Genscript Biotech Corporation Life Science Products Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Genscript Biotech Corporation Life Science Products Product Portfolio Table 96. Genscript Biotech Corporation Recent Development Table 97. Crown Bioscience Company Information Table 98. Crown Bioscience Business Overview Table 99. Crown Bioscience Life Science Products Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Crown Bioscience Life Science Products Product Portfolio Table 101. Crown Bioscience Recent Development Table 102. BPS Bioscience Company Information Table 103. BPS Bioscience Business Overview Table 104. BPS Bioscience Life Science Products Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. BPS Bioscience Life Science Products Product Portfolio Table 106. BPS Bioscience Recent Development Table 107. Bio-Rad Laboratories Company Information Table 108. Bio-Rad Laboratories Business Overview Table 109. Bio-Rad Laboratories Life Science Products Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Bio-Rad Laboratories Life Science Products Product Portfolio Table 111. Bio-Rad Laboratories Recent Development Table 112. Abcam Company Information Table 113. Abcam Business Overview Table 114. Abcam Life Science Products Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Abcam Life Science Products Product Portfolio Table 116. Abcam Recent Development Table 117. A.M.S. Biotechnology (Europe) Company Information Table 118. A.M.S. Biotechnology (Europe) Business Overview Table 119. A.M.S. Biotechnology (Europe) Life Science Products Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. A.M.S. Biotechnology (Europe) Life Science Products Product Portfolio Table 121. A.M.S. Biotechnology (Europe) Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Life Science Products Distributors List Table 125. Life Science Products Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Life Science Products Product Image Figure 2. Global Life Science Products Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Life Science Products Sales Value (2021-2032) & (US$ Million) Figure 4. Global Life Science Products Sales (2021-2032) & (W Units) Figure 5. Global Life Science Products Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Life Science Products Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Recombinant Proteins Image Figure 10. Tumor Tissue Microarrays Image Figure 11. Cell Lines Image Figure 12. Antibodies Image Figure 13. Viable Tumor Samples Image Figure 14. Others Image Figure 15. Global Life Science Products Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Life Science Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Life Science Products Sales Volume Share by Type (2021-2032) Figure 18. Global Life Science Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Life Science Products Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Life Science Products Sales Value Share by Type (2021-2032) Figure 21. Forensic Science Laboratories Image Figure 22. Contract Research Organizations (CROs) Image Figure 23. Biopharmaceutical Companies Image Figure 24. Food & Beverage Companies Image Figure 25. Academic & Research Institutes Image Figure 26. Diagnostic Centers Image Figure 27. Others Image Figure 28. Global Life Science Products Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 29. Global Life Science Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 30. Global Life Science Products Sales Volume Share by Application (2021-2032) Figure 31. Global Life Science Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Life Science Products Sales Value Share 2021 VS 2025 VS 2032 Figure 33. Global Life Science Products Sales Value Share by Application (2021-2032) Figure 34. Global Life Science Products Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 35. Global Life Science Products Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 36. Global Life Science Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. Global Life Science Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 38. North America Life Science Products Sales Value (2021-2032) & (US$ Million) Figure 39. North America Life Science Products Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Europe Life Science Products Sales Value (2021-2032) & (US$ Million) Figure 41. Europe Life Science Products Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Asia-Pacific Life Science Products Sales Value (2021-2032) & (US$ Million) Figure 43. Asia-Pacific Life Science Products Sales Value Share by Country (%), 2025 VS 2032 Figure 44. South America Life Science Products Sales Value (2021-2032) & (US$ Million) Figure 45. South America Life Science Products Sales Value Share by Country (%), 2025 VS 2032 Figure 46. Middle East & Africa Life Science Products Sales Value (2021-2032) & (US$ Million) Figure 47. Middle East & Africa Life Science Products Sales Value Share by Country (%), 2025 VS 2032 Figure 48. USA Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. USA Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. USA Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Canada Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Canada Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Canada Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Mexico Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Mexico Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Mexico Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Germany Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Germany Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Germany Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. France Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. France Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. France Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. U.K. Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. U.K. Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. U.K. Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Italy Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Italy Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Italy Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Spain Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Spain Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Spain Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Russia Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Russia Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Russia Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Netherlands Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Netherlands Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Netherlands Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Nordic Countries Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Nordic Countries Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Nordic Countries Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. China Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. China Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. China Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Japan Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Japan Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Japan Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. South Korea Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. South Korea Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. South Korea Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. India Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. India Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. India Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Australia Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Australia Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Australia Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Southeast Asia Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Southeast Asia Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Southeast Asia Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Brazil Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Brazil Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Brazil Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Argentina Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Argentina Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Argentina Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Chile Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Chile Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Chile Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Colombia Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Colombia Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Colombia Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Peru Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Peru Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Peru Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Saudi Arabia Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Saudi Arabia Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Israel Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Israel Arabia Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Israel Arabia Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. UAE Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. UAE Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. UAE Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Turkey Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Turkey Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Turkey Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Iran Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Iran Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Iran Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Egypt Life Science Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 130. Egypt Life Science Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 131. Egypt Life Science Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 132. Life Science Products Value Chain Figure 133. Manufacturing Cost Structure Figure 134. Life Science Products Sales Mode & Process Figure 135. Direct Comparison with Distribution Share Figure 136. Distributors Profiles Figure 137. Years Considered Figure 138. Research Process Figure 139. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Proteins
  • Tumor Tissue Microarrays
  • Cell Lines
  • Antibodies
  • Viable Tumor Samples
  • Others
Applications
  • Forensic Science Laboratories
  • Contract Research Organizations (CROs)
  • Biopharmaceutical Companies
  • Food & Beverage Companies
  • Academic & Research Institutes
  • Diagnostic Centers
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Sigma Aldrich Corp
  • PerkinElmer
  • Merck Millipore Limited
  • Genscript Biotech Corporation
  • Crown Bioscience
  • BPS Bioscience
  • Bio-Rad Laboratories
  • Abcam
  • A.M.S. Biotechnology (Europe)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Life Science Products Sales Value (2021-2032)
  4. 1.2.2 Global Life Science Products Sales Volume (2021-2032)
  5. 1.2.3 Global Life Science Products Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Life Science Products Market Dynamics
  1. 2.1 Life Science Products Industry Trends
  2. 2.2 Life Science Products Industry Drivers
  3. 2.3 Life Science Products Industry Opportunities and Challenges
  4. 2.4 Life Science Products Industry Restraints
3 Life Science Products Market by Company
  1. 3.1 Global Life Science Products Company Revenue Ranking in 2025
  2. 3.2 Global Life Science Products Revenue by Company (2021-2026)
  3. 3.3 Global Life Science Products Sales Volume by Company (2021-2026)
  4. 3.4 Global Life Science Products Average Price by Company (2021-2026)
  5. 3.5 Global Life Science Products Company Ranking (2024-2026)
  6. 3.6 Global Life Science Products Company Manufacturing Base and Headquarters
  7. 3.7 Global Life Science Products Company Product Type and Application
  8. 3.8 Global Life Science Products Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Life Science Products Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Life Science Products Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Life Science Products Market by Type
  1. 4.1 Life Science Products Type Introduction
  2. 4.1.1 Recombinant Proteins
  3. 4.1.2 Tumor Tissue Microarrays
  4. 4.1.3 Cell Lines
  5. 4.1.4 Antibodies
  6. 4.1.5 Viable Tumor Samples
  7. 4.1.6 Others
  8. 4.2 Global Life Science Products Sales Volume by Type
  9. 4.2.1 Global Life Science Products Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Life Science Products Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Life Science Products Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Life Science Products Sales Value by Type
  13. 4.3.1 Global Life Science Products Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Life Science Products Sales Value by Type (2021-2032)
  15. 4.3.3 Global Life Science Products Sales Value Share by Type (2021-2032)
5 Life Science Products Market by Application
  1. 5.1 Life Science Products Application Introduction
  2. 5.1.1 Forensic Science Laboratories
  3. 5.1.2 Contract Research Organizations (CROs)
  4. 5.1.3 Biopharmaceutical Companies
  5. 5.1.4 Food & Beverage Companies
  6. 5.1.5 Academic & Research Institutes
  7. 5.1.6 Diagnostic Centers
  8. 5.1.7 Others
  9. 5.2 Global Life Science Products Sales Volume by Application
  10. 5.2.1 Global Life Science Products Sales Volume by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global Life Science Products Sales Volume by Application (2021-2032)
  12. 5.2.3 Global Life Science Products Sales Volume Share by Application (2021-2032)
  13. 5.3 Global Life Science Products Sales Value by Application
  14. 5.3.1 Global Life Science Products Sales Value by Application (2021 VS 2025 VS 2032)
  15. 5.3.2 Global Life Science Products Sales Value by Application (2021-2032)
  16. 5.3.3 Global Life Science Products Sales Value Share by Application (2021-2032)
6 Life Science Products Regional Sales and Value Analysis
  1. 6.1 Global Life Science Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Life Science Products Sales by Region (2021-2032)
  3. 6.2.1 Global Life Science Products Sales by Region: 2021-2026
  4. 6.2.2 Global Life Science Products Sales by Region (2027-2032)
  5. 6.3 Global Life Science Products Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Life Science Products Sales Value by Region (2021-2032)
  7. 6.4.1 Global Life Science Products Sales Value by Region: 2021-2026
  8. 6.4.2 Global Life Science Products Sales Value by Region (2027-2032)
  9. 6.5 Global Life Science Products Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Life Science Products Sales Value (2021-2032)
  12. 6.6.2 North America Life Science Products Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Life Science Products Sales Value (2021-2032)
  15. 6.7.2 Europe Life Science Products Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Life Science Products Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Life Science Products Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Life Science Products Sales Value (2021-2032)
  21. 6.9.2 South America Life Science Products Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Life Science Products Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Life Science Products Sales Value Share by Country, 2025 VS 2032
7 Life Science Products Country-level Sales and Value Analysis
  1. 7.1 Global Life Science Products Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Life Science Products Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Life Science Products Sales by Country (2021-2032)
  4. 7.3.1 Global Life Science Products Sales by Country (2021-2026)
  5. 7.3.2 Global Life Science Products Sales by Country (2027-2032)
  6. 7.4 Global Life Science Products Sales Value by Country (2021-2032)
  7. 7.4.1 Global Life Science Products Sales Value by Country (2021-2026)
  8. 7.4.2 Global Life Science Products Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Life Science Products Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Life Science Products Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Life Science Products Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Life Science Products Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Life Science Products Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Life Science Products Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Life Science Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Life Science Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Life Science Products Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Life Science Products Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Life Science Products Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Life Science Products Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Life Science Products Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Life Science Products Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Life Science Products Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Life Science Products Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Life Science Products Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Life Science Products Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Life Science Products Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Life Science Products Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Life Science Products Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Life Science Products Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Life Science Products Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Life Science Products Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Life Science Products Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Life Science Products Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Life Science Products Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Life Science Products Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Life Science Products Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Life Science Products Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Life Science Products Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Life Science Products Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Life Science Products Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Life Science Products Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Life Science Products Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Life Science Products Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Life Science Products Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Life Science Products Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Life Science Products Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Life Science Products Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Life Science Products Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Life Science Products Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Life Science Products Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Life Science Products Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Life Science Products Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Life Science Products Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Life Science Products Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Life Science Products Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Life Science Products Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Life Science Products Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Life Science Products Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Life Science Products Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Life Science Products Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Life Science Products Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Life Science Products Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Life Science Products Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Life Science Products Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Life Science Products Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Life Science Products Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Life Science Products Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Life Science Products Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Life Science Products Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Life Science Products Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Life Science Products Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Life Science Products Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Life Science Products Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Life Science Products Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Life Science Products Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Life Science Products Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Life Science Products Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Life Science Products Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Life Science Products Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Life Science Products Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Life Science Products Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Life Science Products Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Life Science Products Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Life Science Products Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Life Science Products Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Life Science Products Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Life Science Products Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Life Science Products Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Life Science Products Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Life Science Products Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Life Science Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Life Science Products Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Life Science Products Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Sigma Aldrich Corp
  8. 8.2.1 Sigma Aldrich Corp Company Information
  9. 8.2.2 Sigma Aldrich Corp Business Overview
  10. 8.2.3 Sigma Aldrich Corp Life Science Products Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sigma Aldrich Corp Life Science Products Product Portfolio
  12. 8.2.5 Sigma Aldrich Corp Recent Developments
  13. 8.3 PerkinElmer
  14. 8.3.1 PerkinElmer Company Information
  15. 8.3.2 PerkinElmer Business Overview
  16. 8.3.3 PerkinElmer Life Science Products Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 PerkinElmer Life Science Products Product Portfolio
  18. 8.3.5 PerkinElmer Recent Developments
  19. 8.4 Merck Millipore Limited
  20. 8.4.1 Merck Millipore Limited Company Information
  21. 8.4.2 Merck Millipore Limited Business Overview
  22. 8.4.3 Merck Millipore Limited Life Science Products Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Millipore Limited Life Science Products Product Portfolio
  24. 8.4.5 Merck Millipore Limited Recent Developments
  25. 8.5 Genscript Biotech Corporation
  26. 8.5.1 Genscript Biotech Corporation Company Information
  27. 8.5.2 Genscript Biotech Corporation Business Overview
  28. 8.5.3 Genscript Biotech Corporation Life Science Products Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Genscript Biotech Corporation Life Science Products Product Portfolio
  30. 8.5.5 Genscript Biotech Corporation Recent Developments
  31. 8.6 Crown Bioscience
  32. 8.6.1 Crown Bioscience Company Information
  33. 8.6.2 Crown Bioscience Business Overview
  34. 8.6.3 Crown Bioscience Life Science Products Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Crown Bioscience Life Science Products Product Portfolio
  36. 8.6.5 Crown Bioscience Recent Developments
  37. 8.7 BPS Bioscience
  38. 8.7.1 BPS Bioscience Company Information
  39. 8.7.2 BPS Bioscience Business Overview
  40. 8.7.3 BPS Bioscience Life Science Products Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 BPS Bioscience Life Science Products Product Portfolio
  42. 8.7.5 BPS Bioscience Recent Developments
  43. 8.8 Bio-Rad Laboratories
  44. 8.8.1 Bio-Rad Laboratories Company Information
  45. 8.8.2 Bio-Rad Laboratories Business Overview
  46. 8.8.3 Bio-Rad Laboratories Life Science Products Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bio-Rad Laboratories Life Science Products Product Portfolio
  48. 8.8.5 Bio-Rad Laboratories Recent Developments
  49. 8.9 Abcam
  50. 8.9.1 Abcam Company Information
  51. 8.9.2 Abcam Business Overview
  52. 8.9.3 Abcam Life Science Products Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Abcam Life Science Products Product Portfolio
  54. 8.9.5 Abcam Recent Developments
  55. 8.10 A.M.S. Biotechnology (Europe)
  56. 8.10.1 A.M.S. Biotechnology (Europe) Company Information
  57. 8.10.2 A.M.S. Biotechnology (Europe) Business Overview
  58. 8.10.3 A.M.S. Biotechnology (Europe) Life Science Products Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 A.M.S. Biotechnology (Europe) Life Science Products Product Portfolio
  60. 8.10.5 A.M.S. Biotechnology (Europe) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Life Science Products Value Chain Analysis
  2. 9.1.1 Life Science Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Life Science Products Sales Mode & Process
  6. 9.2 Life Science Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Life Science Products Distributors
  9. 9.2.3 Life Science Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research